IGF1 and cancer: In addition, insulin may promote malignant transformation, cancer progression and metastasis through binding and activation of the IGF-1 receptor, and hyperglycaemia itself may increase cellular sensitivity to IGF-1, further contributing to cancer development and progression (25, 26).